254 related articles for article (PubMed ID: 9649915)
41. Pregnancy after removal of Norplant implants contraceptive.
Affandi B; Santoso SS; Djajadilaga ; Hadisaputra W; Moeloek FA; Prihartono J; Lubis F; Samil RS
Contraception; 1987 Aug; 36(2):203-9. PubMed ID: 3123134
[TBL] [Abstract][Full Text] [Related]
42. Subdermal contraceptive implants in nurse-midwifery practice.
Emerling JM; Paluzzi P; Leiva J; Cullins VE
J Nurse Midwifery; 1993; 38(2 Suppl):80S-87S. PubMed ID: 8483013
[TBL] [Abstract][Full Text] [Related]
43. Reduced endothelial cell migratory signal production by endometrial explants from women using Norplant contraception.
Subakir SB; Hadisaputra W; Siregar B; Irawati D; Santoso DI; Cornain S; Affandi B
Hum Reprod; 1995 Oct; 10(10):2579-83. PubMed ID: 8567774
[TBL] [Abstract][Full Text] [Related]
44. Use of levonorgestrel implants versus oral contraceptives in adolescence: a case-control study.
Berenson AB; Wiemann CM
Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1128-35; discussion 1135-7. PubMed ID: 7726249
[TBL] [Abstract][Full Text] [Related]
45. Education and counseling for Norplant users.
Hinkle LT
J Obstet Gynecol Neonatal Nurs; 1994 Jun; 23(5):387-91. PubMed ID: 8083779
[TBL] [Abstract][Full Text] [Related]
46. Return of fertility following discontinuation of Norplant-II subdermal implants. ICMR Task Force on Hormonal Contraception.
Buckshee K; Chatterjee P; Dhall GI; Hazra MN; Kodkany BS; Lalitha K; Logambal A; Manchanda P; Nanda UK; RaiChoudhury G
Contraception; 1995 Apr; 51(4):237-42. PubMed ID: 7796589
[TBL] [Abstract][Full Text] [Related]
47. Subjective perception of bleeding and serum ferritin concentration in long-term users of Norplant.
Faundes A; Tejada AS; Brache V; Alvarez F
Contraception; 1987 Feb; 35(2):189-96. PubMed ID: 3109804
[TBL] [Abstract][Full Text] [Related]
48. Management of irregular uterine bleeding and spotting associated with Norplant.
Archer DF; Philput CA; Weber ME
Hum Reprod; 1996 Oct; 11 Suppl 2():24-30. PubMed ID: 8982742
[TBL] [Abstract][Full Text] [Related]
49. Norplant implants in the UK: first year continuation and removals.
Peers T; Stevens JE; Graham J; Davey A
Contraception; 1996 Jun; 53(6):345-51. PubMed ID: 8773421
[TBL] [Abstract][Full Text] [Related]
50. Norplant implants and cardiovascular disease.
Petitti DB; Siscovick DS; Sidney S; Schwartz SM; Quesenberry CP; Psaty BM; Raghunathan TE; Koepsell TD; Longstreth WT
Contraception; 1998 May; 57(5):361-2. PubMed ID: 9673845
[TBL] [Abstract][Full Text] [Related]
51. Endometrial angiogenic response in Norplant users.
Subakir SB; Hadisaputra W; Handoyo AE; Affandi B
Hum Reprod; 1996 Oct; 11 Suppl 2():51-5. PubMed ID: 8982746
[TBL] [Abstract][Full Text] [Related]
52. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
[TBL] [Abstract][Full Text] [Related]
53. Hormonal treatment for bleeding irregularities in Norplant implant users.
Alvarez-Sanchez F; Brache V; Thevenin F; Cochon L; Faundes A
Am J Obstet Gynecol; 1996 Mar; 174(3):919-22. PubMed ID: 8633669
[TBL] [Abstract][Full Text] [Related]
54. Immunohistochemical staining of von Willebrand factor in endometrium of women during the first year of Norplant implants use.
Au CL; Affandi B; Rogers PA
Contraception; 1994 Nov; 50(5):477-89. PubMed ID: 7859456
[TBL] [Abstract][Full Text] [Related]
55. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
Clark DA; Wang S; Rogers P; Vince G; Affandi B
Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
[TBL] [Abstract][Full Text] [Related]
56. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P
Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
[TBL] [Abstract][Full Text] [Related]
57. Norplant: what health educators need to know.
Ogletree RJ; Welshimer KJ
J Health Educ; 1994; 25(4):230-3. PubMed ID: 12288963
[TBL] [Abstract][Full Text] [Related]
58. Endometrial vasculature in Norplant users: preliminary results from a hysteroscopic study.
Hickey M; Fraser I; Dwarte D; Graham S
Hum Reprod; 1996 Oct; 11 Suppl 2():35-44. PubMed ID: 8982744
[TBL] [Abstract][Full Text] [Related]
59. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.
Cromer BA; Smith RD; Blair JM; Dwyer J; Brown RT
Pediatrics; 1994 Nov; 94(5):687-94. PubMed ID: 7936897
[TBL] [Abstract][Full Text] [Related]
60. Acceptance, efficacy, and side effects of Norplant implants in four counties in north China.
Tu P; Qiu S; Fang H; Smith HL
Stud Fam Plann; 1997 Jun; 28(2):122-31. PubMed ID: 9216032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
